{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:19Z","timestamp":1790882419761,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cFonds National de la Recherche Scientifique\u201d (FNRS)"},{"name":"T\u00e9l\u00e9vie"},{"name":"Belgian Foundation Against Cancer"},{"name":"Sixth Research Framework Programme of the European Union","award":["INCA LSHC-CT-2005-018704"],"award-info":[{"award-number":["INCA LSHC-CT-2005-018704"]}]},{"name":"\u201cNeoangio\u201d Excellence Program and the \u201cPartenariat Public Priv\u00e9\u201d PPP INCA of the \u201cDirection g\u00e9n\u00e9rale des Technologies"},{"name":"de la Recherche et de l'Energie\/DG06\u201d of the Walloon Government"},{"name":"\u201cAction de Recherche Concert\u00e9e Glyvir\u201d of the \u201cCommunaut\u00e9 fran\u00e7aise de Belgique\u201d"},{"name":"\u201cCentre anticanc\u00e9reux pr\u00e8s ULg\u201d (CAC)"},{"name":"\u201cSynbiofor\u201d and \u201cAgricultureislife\u201d projects of GxABT"},{"name":"\u201cULg Fonds Sp\u00e9ciaux pour la Recherche\u201d"},{"name":"\u201cPlan Cancer\u201d of the \u201cService Public F\u00e9d\u00e9ral,\u201d"},{"name":"Interuniversity Attraction Poles (IAP) Phase VII BELVIR"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vph.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T17:46:06Z","timestamp":1390067166000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network"],"prefix":"10.1016","volume":"60","author":[{"given":"T.V.","family":"Shiva Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7070","key":"10.1016\/j.vph.2014.01.003_bb0005","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"issue":"7070","key":"10.1016\/j.vph.2014.01.003_bb0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0020","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.4317\/medoral.17395","article-title":"The role of mast cells on angiogenesis in oral squamous cell carcinoma","volume":"17","author":"Kalra","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"6658","key":"10.1016\/j.vph.2014.01.003_bb0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vph.2014.01.003_bb0030","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrclinonc.2009.64","article-title":"Branching morphogenesis anda antiangiogenesis candidates: tip cells lead the way","volume":"6","author":"Carmeliet","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.vph.2014.01.003_bb0040","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.3390\/ijms12128661","article-title":"A concise review on epigenetic regulation: insight into molecular mechanisms","volume":"12","author":"Golbabapour","year":"2011","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semnephrol.2012.02.009","article-title":"Gene regulation in the vascular endothelium: why epigenetics is important for the kidney","volume":"32","author":"Jamal","year":"2012","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0050","first-page":"76","article-title":"Dual targeting of epigenetic therapy in cancer","volume":"1775","author":"Hellebrekers","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"6921","key":"10.1016\/j.vph.2014.01.003_bb0055","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature01411","article-title":"Controlling the double helix","volume":"421","author":"Felsenfeld","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3892\/or.2013.2523","article-title":"Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA","volume":"30","author":"Cheng","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.vph.2014.01.003_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2490-12-21","article-title":"Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression","volume":"12","author":"Byler","year":"2012","journal-title":"BMC Urol"},{"issue":"19","key":"10.1016\/j.vph.2014.01.003_bb0070","first-page":"6299","article-title":"Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma","volume":"63","author":"Yang","year":"2003","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.vph.2014.01.003_bb0075","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1038\/sj.onc.1202663","article-title":"Methylation and silencing of the thrombospondin-1 promoter in human cancer","volume":"18","author":"Li","year":"1999","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.vph.2014.01.003_bb0080","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/1078-0432.CCR-04-0516","article-title":"The in vitro and in vivo effects of re-expressing methylated von Hippel\u2013Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2\u2032-deoxycytidine","volume":"10","author":"Alleman","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.vph.2014.01.003_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jnci\/95.5.399","article-title":"Inhibition of DNA methylation and reactivation of silenced genes by zebularine","volume":"95","author":"Cheng","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.vph.2014.01.003_bb0090","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1158\/0008-5472.CAN-04-0540","article-title":"The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787\/ZK222584","volume":"64","author":"Qian","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02478931","article-title":"Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells","volume":"19","author":"Sawa","year":"2002","journal-title":"Brain Tumor Pathol"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.vph.2014.01.003_bb0105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1535-6108(03)00165-X","article-title":"Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?","volume":"4","author":"Johnstone","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.vph.2014.01.003_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-230X(04)91004-4","article-title":"Histone deacetylase inhibitors","volume":"91","author":"Marks","year":"2004","journal-title":"Adv Cancer Res"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","article-title":"Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics","volume":"3","author":"Eberharter","year":"2002","journal-title":"EMBO Rep"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/excr.2001.5187","article-title":"Histone acetylation and chromatin remodeling","volume":"265","author":"Gregory","year":"2001","journal-title":"Exp Cell Res"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.20372","article-title":"Histone deacetylase inhibitors: understanding a new wave of anticancer agents","volume":"112","author":"Villar-Garea","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vph.2014.01.003_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.biochem.70.1.81","article-title":"Histone acetyltransferases","volume":"70","author":"Roth","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vph.2014.01.003_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylases: unique players in shaping the epigenetic histone code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"37","key":"10.1016\/j.vph.2014.01.003_bb0150","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","article-title":"Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes","volume":"7","author":"Kim","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.109.890491","article-title":"Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow","volume":"121","author":"Zampetaki","year":"2010","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.vph.2014.01.003_bb0165","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1182\/blood-2009-01-196485","article-title":"HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells","volume":"113","author":"Urbich","year":"2009","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.vph.2014.01.003_bb0170","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1038\/emboj.2011.298","article-title":"Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin","volume":"30","author":"Kaluza","year":"2011","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10","volume":"126","author":"Chang","year":"2006","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.vph.2014.01.003_bb0180","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCRESAHA.107.149377","article-title":"Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis","volume":"101","author":"Mottet","year":"2007","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/ATVBAHA.112.300415","article-title":"Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells","volume":"33","author":"Kaluza","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2014.01.003_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2012\/597514","article-title":"Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells","volume":"2012","author":"Lappas","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/epi.1.1.2644","article-title":"Histone deacetylase inhibitors for cancer therapy","volume":"1","author":"Kim","year":"2006","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0205","first-page":"151","article-title":"Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines","volume":"2","author":"Glaser","year":"2003","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ctrv.2005.12.006","article-title":"Histone deacetylase inhibitors: multifunctional anticancer agents","volume":"32","author":"Liu","year":"2006","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.2536759100","article-title":"Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications","volume":"101","author":"Mitsiades","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.vph.2014.01.003_bb0220","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1073\/pnas.0500369102","article-title":"Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors","volume":"102","author":"Peart","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0225","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1124\/mol.105.014167","article-title":"Rational development of histone deacetylase inhibitors as anticancer agents: a review","volume":"68","author":"Acharya","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"17","key":"10.1016\/j.vph.2014.01.003_bb0230","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2005.16.600","article-title":"Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies","volume":"23","author":"Bhalla","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vph.2014.01.003_bb0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","article-title":"Clinical development of histone deacetylase inhibitors as anticancer agents","volume":"45","author":"Drummond","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0240","first-page":"166","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am. J Transl Res"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2004.10.001","article-title":"Histone deacetylase inhibitors","volume":"40","author":"Monneret","year":"2005","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0250","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/ol702957z","article-title":"Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228)","volume":"10","author":"Greshock","year":"2008","journal-title":"Org Lett"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0255","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0260","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1535-7163.MCT-05-0417","article-title":"Angiostatic activity of DNA methyltransferase inhibitors","volume":"5","author":"Hellebrekers","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"6B","key":"10.1016\/j.vph.2014.01.003_bb0265","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/j.1582-4934.2008.00515.x","article-title":"Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis","volume":"12","author":"Buysschaert","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"20","key":"10.1016\/j.vph.2014.01.003_bb0270","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1101\/gad.924501","article-title":"FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity","volume":"15","author":"Mahon","year":"2001","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10555-010-9253-0","article-title":"DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability","volume":"29","author":"Sahin","year":"2010","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0280","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.onc.1205108","article-title":"Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling","volume":"21","author":"Deroanne","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1083\/jcb.146.1.233","article-title":"Neuropilin-1 mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165","volume":"146","author":"Miao","year":"1999","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","article-title":"Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha","volume":"14","author":"Ravi","year":"2000","journal-title":"Genes Dev"},{"issue":"11","key":"10.1016\/j.vph.2014.01.003_bb0295","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00005072-199711000-00009","article-title":"Putative control of angiogenesis in hemangioblastomas by the von Hippel\u2013Lindau tumor suppressor gene","volume":"56","author":"Stratmann","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/mp.51.2.55","article-title":"Response of tumour cells to hypoxia: role of p53 and NFkB","volume":"51","author":"Royds","year":"1998","journal-title":"Mol Pathol"},{"issue":"9","key":"10.1016\/j.vph.2014.01.003_bb0305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.RES.0000037983.07158.B1","article-title":"Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis","volume":"91","author":"Rossig","year":"2002","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.vph.2014.01.003_bb0310","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0315","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.CIR.104.3.342","article-title":"Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase","volume":"104","author":"Duplain","year":"2001","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.vph.2014.01.003_bb0320","doi-asserted-by":"crossref","first-page":"24824","DOI":"10.1074\/jbc.M502115200","article-title":"The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code","volume":"280","author":"Fish","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.vph.2014.01.003_bb0325","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/CIRCRESAHA.111.247304","article-title":"Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells","volume":"109","author":"Ohtani","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.vph.2014.01.003_bb0330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00395-012-0283-3","article-title":"Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells","volume":"107","author":"Siuda","year":"2012","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0335","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.111.030775","article-title":"NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation","volume":"124","author":"Craige","year":"2011","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.vph.2014.01.003_bb0340","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1158\/0008-5472.CAN-06-1609","article-title":"Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications","volume":"66","author":"Hellebrekers","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.vph.2014.01.003_bb0345","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1161\/01.ATV.0000247247.89787.e7","article-title":"Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression","volume":"26","author":"Inoue","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"39","key":"10.1016\/j.vph.2014.01.003_bb0350","doi-asserted-by":"crossref","first-page":"28408","DOI":"10.1074\/jbc.M703586200","article-title":"Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vph.2014.01.003_bb0355","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nm1037","article-title":"Regulation of angiogenesis by tissue factor cytoplasmic domain signaling","volume":"10","author":"Belting","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1582-4934.2002.tb00307.x","article-title":"Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth","volume":"6","author":"Lawler","year":"2002","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10.1016\/j.vph.2014.01.003_bb0365","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/0008-5472.CAN-06-3032","article-title":"Identification of epigenetically silenced genes in tumor endothelial cells","volume":"67","author":"Hellebrekers","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0370","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1074\/jbc.M110.146860","article-title":"Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism","volume":"286","author":"Ma","year":"2011","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.vph.2014.01.003_bb0375","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-11-1523","article-title":"Binding of the JmjC demethylase JARID1B to LSD1\/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.vph.2014.01.003_bb0380","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mc.20829","article-title":"Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo","volume":"51","author":"Wang","year":"2012","journal-title":"Mol Carcinog"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0385","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1582-4934.2007.00061.x","article-title":"Role of the soluble pattern recognition receptor PTX3 in vascular biology","volume":"11","author":"Presta","year":"2007","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0390","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.bbrc.2005.10.004","article-title":"Annexin A3 is a potential angiogenic mediator","volume":"337","author":"Park","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vph.2014.01.003_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/234629","article-title":"Involvement of fatty acid binding protein 5 and PPARbeta\/delta in prostate cancer cell growth","volume":"2010","author":"Morgan","year":"2010","journal-title":"PPAR Res"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0400","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.surg.2011.07.001","article-title":"Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro","volume":"150","author":"Jin","year":"2011","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0405","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.ATV.0000251517.98396.4a","article-title":"A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration","volume":"27","author":"Ng","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0410","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ydbio.2009.02.033","article-title":"Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation","volume":"329","author":"Xu","year":"2009","journal-title":"Dev Biol"},{"issue":"23","key":"10.1016\/j.vph.2014.01.003_bb0415","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.4161\/cbt.8.23.10138","article-title":"Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells","volume":"8","author":"Tahir","year":"2009","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"10.1016\/j.vph.2014.01.003_bb0420","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1745-7254.2006.00462.x","article-title":"Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells","volume":"27","author":"Pan","year":"2006","journal-title":"Acta Pharmacol Sin"},{"issue":"28","key":"10.1016\/j.vph.2014.01.003_bb0425","doi-asserted-by":"crossref","first-page":"25902","DOI":"10.1074\/jbc.M300358200","article-title":"Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect","volume":"278","author":"Nam","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0430","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.ATV.0000254147.89321.cf","article-title":"Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis","volume":"27","author":"Ivanciu","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.vph.2014.01.003_bb0435","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1182\/blood-2011-04-349910","article-title":"Safety of long-term treatment of HAM\/TSP patients with valproic acid","volume":"118","author":"Olindo","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0440","doi-asserted-by":"crossref","first-page":"e31573","DOI":"10.1371\/journal.pone.0031573","article-title":"Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression","volume":"7","author":"Larsson","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vph.2014.01.003_bb0445","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1189\/jlb.0805448","article-title":"Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin","volume":"79","author":"Egami","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0450","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI23445","article-title":"Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation","volume":"115","author":"Garmy-Susini","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0455","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling","volume":"122","author":"Felcht","year":"2012","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0460","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijc.1602","article-title":"Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis","volume":"97","author":"Kwon","year":"2002","journal-title":"Int J Cancer"},{"issue":"6535","key":"10.1016\/j.vph.2014.01.003_bb0465","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","article-title":"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice","volume":"376","author":"Shalaby","year":"1995","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vph.2014.01.003_bb0470","first-page":"3137","article-title":"A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library","volume":"60","author":"Su","year":"2000","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.vph.2014.01.003_bb0475","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(88)90147-X","article-title":"c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities","volume":"55","author":"Halazonetis","year":"1988","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.vph.2014.01.003_bb0480","doi-asserted-by":"crossref","first-page":"e45331","DOI":"10.1371\/journal.pone.0045331","article-title":"SIRT1 regulates endothelial Notch signaling in lung cancer","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS One"},{"issue":"7183","key":"10.1016\/j.vph.2014.01.003_bb0485","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature06640","article-title":"Transient cyclical methylation of promoter DNA","volume":"452","author":"Kangaspeska","year":"2008","journal-title":"Nature"},{"issue":"7183","key":"10.1016\/j.vph.2014.01.003_bb0490","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature06544","article-title":"Cyclical DNA methylation of a transcriptionally active promoter","volume":"452","author":"Metivier","year":"2008","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vph.2014.01.003_bb0495","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1101\/gad.2.9.1136","article-title":"Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter","volume":"2","author":"Watt","year":"1988","journal-title":"Genes Dev"},{"issue":"6683","key":"10.1016\/j.vph.2014.01.003_bb0500","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vph.2014.01.003_bb0505","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","article-title":"Identification and characterization of a family of mammalian methyl-CpG binding proteins","volume":"18","author":"Hendrich","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0510","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0092-8674(91)90267-3","article-title":"DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein","volume":"64","author":"Boyes","year":"1991","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.vph.2014.01.003_bb0515","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/j.1460-2075.1992.tb05326.x","article-title":"Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain","volume":"11","author":"Bestor","year":"1992","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0520","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/77124","article-title":"DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters","volume":"25","author":"Robertson","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/77023","article-title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci","volume":"25","author":"Rountree","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0530","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/excr.2000.5080","article-title":"The human histone deacetylase family","volume":"262","author":"Gray","year":"2001","journal-title":"Exp Cell Res"},{"issue":"6861","key":"10.1016\/j.vph.2014.01.003_bb0535","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/35104508","article-title":"A histone H3 methyltransferase controls DNA methylation in Neurospora crassa","volume":"414","author":"Tamaru","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrg2932","article-title":"Silencing chromatin: comparing modes and mechanisms","volume":"12","author":"Beisel","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0545","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1073\/pnas.97.1.377","article-title":"Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation","volume":"97","author":"Chen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1535-6108(02)00234-9","article-title":"Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene","volume":"3","author":"Bachman","year":"2003","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.vph.2014.01.003_bb0555","doi-asserted-by":"crossref","first-page":"9430","DOI":"10.1073\/pnas.95.16.9430","article-title":"Trichostatin A causes selective loss of DNA methylation in Neurospora","volume":"95","author":"Selker","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vph.2014.01.003_bb0560","series-title":"Epigenetic aspects of chronic diseases","first-page":"41","article-title":"Mechanisms of epigenetic gene silencing","author":"Lambert","year":"2011"},{"issue":"1\u20132","key":"10.1016\/j.vph.2014.01.003_bb0565","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","article-title":"Epigenetic interplay between histone modifications and DNA methylation in gene silencing","volume":"659","author":"Vaissiere","year":"2008","journal-title":"Mutat Res"},{"issue":"25","key":"10.1016\/j.vph.2014.01.003_bb0570","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/CIRCULATIONAHA.111.033092","article-title":"Epigenetic control of angiogenesis via DNA methylation","volume":"123","author":"Cooper","year":"2011","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.vph.2014.01.003_bb0575","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1161\/CIRCULATIONAHA.110.966408","article-title":"Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury","volume":"123","author":"Rao","year":"2011","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.vph.2014.01.003_bb0580","doi-asserted-by":"crossref","first-page":"35087","DOI":"10.1074\/jbc.M405063200","article-title":"The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation","volume":"279","author":"Chan","year":"2004","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1016\/j.vph.2014.01.003_bb0585","doi-asserted-by":"crossref","first-page":"16467","DOI":"10.1074\/jbc.M412960200","article-title":"Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase","volume":"280","author":"Gan","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0590","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1152\/japplphysiol.00131.2010","article-title":"Epigenetics of the vascular endothelium","volume":"109","author":"Yan","year":"2010","journal-title":"J Appl Physiol"},{"issue":"7","key":"10.1016\/j.vph.2014.01.003_bb0595","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/ijc.24108","article-title":"Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker","volume":"124","author":"Sadr-Nabavi","year":"2009","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.vph.2014.01.003_bb0600","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1128\/MCB.25.11.4727-4741.2005","article-title":"5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal","volume":"25","author":"Ghoshal","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0605","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopha.2007.07.015","article-title":"5-Aza-2\u2032-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells","volume":"62","author":"Miller-Kasprzak","year":"2008","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"10.1016\/j.vph.2014.01.003_bb0610","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0960-9822(03)00432-9","article-title":"Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin","volume":"13","author":"Lehnertz","year":"2003","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.vph.2014.01.003_bb0615","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/71750","article-title":"DNA methyltransferase Dnmt1 associates with histone deacetylase activity","volume":"24","author":"Fuks","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0620","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood-2004-06-2315","article-title":"Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0625","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2010.08.111","article-title":"Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10\/Ankyrin repeats","volume":"400","author":"Bargo","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.vph.2014.01.003_bb0630","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/hmg\/ddr062","article-title":"Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers","volume":"20","author":"Miyazaki","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0635","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcp.1041560204","article-title":"Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro","volume":"156","author":"Schnaper","year":"1993","journal-title":"J Cell Physiol"},{"issue":"12","key":"10.1016\/j.vph.2014.01.003_bb0640","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1167\/iovs.03-0249","article-title":"Reduced retinal angiogenesis in MMP-2-deficient mice","volume":"44","author":"Ohno-Matsui","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.vph.2014.01.003_bb0645","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/leu.2008.397","article-title":"The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells","volume":"23","author":"Flotho","year":"2009","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.vph.2014.01.003_bb0650","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.onc.1208287","article-title":"Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3","volume":"24","author":"Iwatsuki","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0655","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10456-012-9274-0","article-title":"Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor\/c-kit pathway","volume":"15","author":"Elmasri","year":"2012","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0660","first-page":"710","article-title":"IL-6 increases endothelial permeability in vitro","volume":"131","author":"Maruo","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2014.01.003_bb0665","article-title":"Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR\/STAT3 pathway","author":"Yang","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0670","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.vph.2014.01.003_bb0675","doi-asserted-by":"crossref","first-page":"e62038","DOI":"10.1371\/journal.pone.0062038","article-title":"The efficacy of bevacizumab compared with other targeted drugs for patients with advanced NSCLC: a meta-analysis from 30 randomized controlled clinical trials","volume":"8","author":"Cui","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2014.01.003_bb0680","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-12-2160","article-title":"Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice","author":"Sennino","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.vph.2014.01.003_bb0685","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/CCO.0b013e32835ff161","article-title":"Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer","volume":"25","author":"MacVicar","year":"2013","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"10.1016\/j.vph.2014.01.003_bb0690","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157488408784293705","article-title":"The molecular basis of class side effects due to treatment with inhibitors of the VEGF\/VEGFR pathway","volume":"3","author":"Roodhart","year":"2008","journal-title":"Curr Clin Pharmacol"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T04:34:37Z","timestamp":1648096477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189114000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1537189114000044"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2014.01.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}